These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 31971602)

  • 1. Psoriasis and Co-morbidity.
    Amin M; Lee EB; Tsai TF; Wu JJ
    Acta Derm Venereol; 2020 Jan; 100(3):adv00033. PubMed ID: 31971602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond skin deep: addressing comorbidities in psoriasis.
    Kovitwanichkanont T; Chong AH; Foley P
    Med J Aust; 2020 Jun; 212(11):528-534. PubMed ID: 32388913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical challenges faced in real-world management of moderate-to-severe psoriasis: a personal view.
    Cerio R
    G Ital Dermatol Venereol; 2017 Dec; 152(6):551-554. PubMed ID: 28895665
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and Safety of Biologics for Psoriasis and Psoriatic Arthritis and Their Impact on Comorbidities: A Literature Review.
    Kamata M; Tada Y
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32121574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of biologic agents and other disease-modifying antirheumatic drugs on cardiovascular outcomes in psoriasis and psoriatic arthritis: a systematic review.
    Armstrong AW; Brezinski EA; Follansbee MR; Armstrong EJ
    Curr Pharm Des; 2014; 20(4):500-12. PubMed ID: 23565631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Integrated approach to comorbidity in patients with psoriasis.Working Group on Psoriasis-associated Comorbidities].
    Daudén E; Castañeda S; Suárez C; García-Campayo J; Blasco AJ; Aguilar MD; Ferrándiz C; Puig L; Sánchez-Carazo JL;
    Actas Dermosifiliogr; 2012 Jan; 103 Suppl 1():1-64. PubMed ID: 22364603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis.
    Husted JA; Thavaneswaran A; Chandran V; Eder L; Rosen CF; Cook RJ; Gladman DD
    Arthritis Care Res (Hoboken); 2011 Dec; 63(12):1729-35. PubMed ID: 21905258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular comorbidities of psoriasis and psoriatic arthritis: a report from the GRAPPA 2012 annual meeting.
    Armstrong AW; Gelfand JM; Boehncke WH; Armstrong EJ
    J Rheumatol; 2013 Aug; 40(8):1434-7. PubMed ID: 23908540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular comorbidities in psoriasis and psoriatic arthritis: pathogenesis, consequences for patient management, and future research agenda: a report from the GRAPPA 2009 annual meeting.
    Boehncke WH; Gladman DD; Chandran V
    J Rheumatol; 2011 Mar; 38(3):567-71. PubMed ID: 21362790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoriasis: classical and emerging comorbidities.
    Oliveira Mde F; Rocha Bde O; Duarte GV
    An Bras Dermatol; 2015; 90(1):9-20. PubMed ID: 25672294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying harmful effects of psoriatic diseases on quality of life: Cardio-metabolic outcomes in psoriatic arthritis study (COMPASS).
    Dalal DS; Lin YC; Brennan DM; Borkar N; Korman N; Husni ME
    Semin Arthritis Rheum; 2015 Jun; 44(6):641-5. PubMed ID: 26058346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comorbidity in connection with psoriasis is more than psoriatic arthritis].
    Kvist-Hansen A; Kaiser H; Skov L; Hansen PR
    Ugeskr Laeger; 2018 Jan; 180(2):. PubMed ID: 29368688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis.
    Puig L
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29295598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comorbidity in psoriasis].
    Gerdes S; Mrowietz U; Boehncke WH
    Hautarzt; 2016 Jun; 67(6):438-44. PubMed ID: 27221798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updates on cardiovascular comorbidities associated with psoriatic diseases: epidemiology and mechanisms.
    Yim KM; Armstrong AW
    Rheumatol Int; 2017 Jan; 37(1):97-105. PubMed ID: 27221457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions.
    Davidovici BB; Sattar N; Prinz J; Puig L; Emery P; Barker JN; van de Kerkhof P; Ståhle M; Nestle FO; Girolomoni G; Krueger JG
    J Invest Dermatol; 2010 Jul; 130(7):1785-96. PubMed ID: 20445552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic immune mechanisms in atopic dermatitis and psoriasis with implications for treatment.
    Guttman-Yassky E; Krueger JG; Lebwohl MG
    Exp Dermatol; 2018 Apr; 27(4):409-417. PubMed ID: 28266782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between smoking, psoriasis and psoriatic arthritis.
    Pezzolo E; Naldi L
    Expert Rev Clin Immunol; 2019 Jan; 15(1):41-48. PubMed ID: 30380949
    [No Abstract]   [Full Text] [Related]  

  • 19. The concept of psoriatic disease: can cutaneous psoriasis any longer be separated by the systemic comorbidities?
    Lotti T; Hercogova J; Prignano F
    Dermatol Ther; 2010; 23(2):119-22. PubMed ID: 20415818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbidities in psoriasis.
    Aurangabadkar SJ
    Indian J Dermatol Venereol Leprol; 2013 Jul; 79 Suppl 7():S10-7. PubMed ID: 23974690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.